Abstract
Most of the licit and illicit drugs consumed by the breastfeeding woman pass into the milk and can modify the production, volume and composition of the milk, as well as hypothetically have short- and long-term harmful effects on the infant. There is much confusion in the scientific community regarding this issue: should a woman breastfeed her baby while continuing to use prescription drugs and/or drugs of abuse? There are many case reports of clinically significant toxicity in breast-fed infants from some substances used by mothers (such as irritability, vomiting, sedation, respiratory depression, shock), but there are too few data on studies conducted in breastfeeding women and their infants to make a realistic risk assessment. The objective measurement of a drug and/or metabolites in maternal milk is the first step when investigating the amount of drug exctreted in milk and subsequently calculating the daily dose administered to the breast-fed infant. The present review reports the analytical methods developed to detect different drugs in the breast milk, listing the principal characteristics and validation parameters, advantages and disadvantges. Furthermore, the mechanisms of drug transfer into breast milk are discussed, the correlation between the concentration of the drug in breast milk and potential adverse outcomes on the infant are described for each drug, and suggested harm minimization strategies and approved breastfeeding recommendations are indicated.
Similar content being viewed by others
Abbreviations
- A:
-
Amphetamines
- AAP:
-
American Academy of Pediatrics
- API:
-
Atmospheric pressure ionization
- BZE:
-
Benzodiazepines
- BEG:
-
Benzoylecgonine
- CAF:
-
Caffeine
- COC:
-
Cocaine
- COT:
-
Cotinine
- ∆-9-THC:
-
Delta-9-tetrahydrocannabinol
- DAD:
-
Diode array detector
- DDP:
-
N-Desmethyldoxepin
- ECD:
-
Electron capture detection
- EDDP:
-
2-Ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine
- EMDP:
-
2-Ethyl-5-methyl-3,3-diphenylpyrroline
- EME:
-
Ecgonine methyl ester
- EIA:
-
Enzyme immunoassay
- EMIT:
-
Enzyme multiplied immunoassay technique
- ESI:
-
Electrospray ionization
- FID:
-
Flame ionization detector
- FPIA:
-
Fluorescence polarization immunoassay
- GC:
-
Gas chromatography
- t 1/2 :
-
Half-life
- HPLC:
-
High-performance liquid chromaqtography
- LC:
-
Liquid chromatography
- MA:
-
Methamphetamine
- 6-MAM:
-
6-Monoacetylmorphine
- MDMA:
-
3,4-Methylenedioxymethamphetamine
- MET:
-
Methadone
- M/P ratio:
-
Milk/plasma ratio
- M6G:
-
Morphine-6-glucuronide
- MS:
-
Mass spectrometry
- MS/MS:
-
Tandem mass spectrometry
- NCI:
-
Negative chemical ionization mode
- NIC:
-
Nicotine
- NPD:
-
Nitrogen phosphorus detector
- PCA:
-
Patient-controlled analgesia
- RIA:
-
Radioimmunoassay
- SSRIs:
-
Selective serotonin reuptake inhibitors
- SPE:
-
Solid-phase extraction
- MS/MS:
-
Tandem mass spectrometry assay
- UV:
-
Ultraviolet
References
Chalmers B, Levitt C, Heaman M, O'Brien B, Sauve R, Kaczorowski J (2009) Breastfeeding rates and hospital breastfeeding practices in Canada: a national survey of women. Birth 36(2):122–132
Kelly YJ, Watt RG (2005) Breast-feeding initiation and exclusive duration at 6 months by social class–results from the Millennium Cohort Study. Public Health Nutr 8(4):417–421
Raisler J, Alexander C, O'Campo P (1999) Breast-feeding and infant illness: a dose-response relationship? Am J Public Health 89(1):25–30
Riordan JM (1997) The cost of not breastfeeding: a commentary. J Hum Lact 13(2):93–97
Dewey KG, Heinig MJ, Nommsen-Rivers LA (1995) Differences in morbidity between breast-fed and formula-fed infants. J Pediatr 126(5 Pt 1):696–702
Oo CY, Kuhn RJ, Desai N, McNamara PJ (1995) Active transport of cimetidine into human milk. Clin Pharmacol Ther 58(5):548–555
Leake RD, Trygstad CW (1977) Glomerular filtration rate during the period of adaptation to extrauterine life. Pediatr Res 11(9 Pt 1):959–962
Lacroix D, Sonnier M, Moncion A, Cheron G, Cresteil T (1997) Expression of CYP3A in the human liver–evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth. Eur J Biochem 247(2):625–634
Bennett (1996) Drugs and human lactation: a comprehensive guide to the content and consequences of drugs, micronutrients, radiopharmaceuticals, and enviromental and occupational chemicals in human milk, 2nd ed. Elsevier, Amsterdam
Pichini S, Garcia-Algar O (2006) In utero exposure to smoking and newborn neurobehavior: how to assess neonatal withdrawal syndrome? Ther Drug Monit 28(3):288–290
Luck W, Nau H (1987) Nicotine and cotinine concentrations in the milk of smoking mothers: influence of cigarette consumption and diurnal variation. Eur J Pediatr 146(1):21–26
Atkinson HC, Begg EJ, Darlow BA (1988) Drugs in human milk. Clinical pharmacokinetic considerations. Clin Pharmacokinet 14(4):217–240
Becker AB, Manfreda J, Ferguson AC, Dimich-Ward H, Watson WT, Chan-Yeung M (1999) Breast-feeding and environmental tobacco smoke exposure. Arch Pediatr Adolesc Med 153(7):689–691
Luck W, Nau H (1984) Nicotine and cotinine concentrations in serum and milk of nursing smokers. Br J Clin Pharmacol 18(1):9–15
Page-Sharp M, Hale TW, Hackett LP, Kristensen JH, Ilett KF (2003) Measurement of nicotine and cotinine in human milk by high-performance liquid chromatography with ultraviolet absorbance detection. J Chromatogr B 796(1):173–180
Ilett KF, Hale TW, Page-Sharp M, Kristensen JH, Kohan R, Hackett LP (2003) Use of nicotine patches in breast-feeding mothers: transfer of nicotine and cotinine into human milk. Clin Pharmacol Ther 74(6):516–524
Dahlstrom A, Ebersjo C, Lundell B (2004) Nicotine exposure in breastfed infants. Acta Paediatr 93(6):810–816
Aresta P (2005) Zambonin. Simultaneous determination of caffeine, theobromine, theophylline, paraxanthine and nicotine in human milk by liquid chromatography with diode array UV detection. Food Chem 93(1):177–181
Pellegrini M, Marchei E, Rossi S, Vagnarelli F, Durgbanshi A, García-Algar O, Vall O, Pichini S (2007) Liquid chromatography/electrospray ionization tandem mass spectrometry assay for determination of nicotine and metabolites, caffeine and arecoline in breast milk. Rapid Commun Mass Spectrom 21(16):2693–2703
Anderson PO, Knoben JE, Troutman WG (2002) Handbook of clinical drug data, 10th edn. McGraw-Hill, New York
Vagnarelli F, Amarri S, Scaravelli G, Pellegrini M, Garcia-Algar O, Pichini S (2006) TDM grand rounds: neonatal nicotine withdrawal syndrome in an infant prenatally and postnatally exposed to heavy cigarette smoke. Ther Drug Monit 28(5):585–588
American Academy of Pediatrics Committee on Drugs (1994) The transfer of drugs and other chemicals into human milk. Pediatrics 93(1):137–150
Woodward A, Douglas RM, Graham NM, Miles H (1990) Acute respiratory illness in Adelaide children: breast feeding modifies the effect of passive smoking. J Epidemiol Commun Health 44(3):224–230
Koren G (2000) Caffeine during pregnancy? In moderation. Can Fam Physician 46:801–803
Briggs GG, Freeman RK, Yaffe SJ (2005) Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk, 7th edn. Lippincott Williams & Wilkins, Philadelphia and London
Ryu JE (1985) Caffeine in human milk and in serum of breast-fed infants. Dev Pharmacol Ther 8(6):329–337
Bailey DN, Weibert RT, Naylor AJ, Shaw RF (1982) A study of salicylate and caffeine excretion in the breast milk of two nursing mothers. J Anal Toxicol 6(2):64–68
Stavchansky S, Combs A, Sagraves R, Delgado M, Joshi A (1988) Pharmacokinetics of caffeine in breast milk and plasma after single oral administration of caffeine to lactating mothers. Biopharm Drug Dispos 9(3):285–299
Blanchard J, Weber CW, Shearer LE (1990) HPLC analysis of methylxanthines in human breast milk. J Chromatogr Sci 28(12):640–642
Oo CY, Burgio DE, Kuhn RC, Desai N, McNamara PJ (1995) Pharmacokinetics of caffeine and its demethylated metabolites in lactation: predictions of milk to serum concentration ratios. Pharm Res 12(2):313–316
McGowan JD, Altman RE, Kanto WP Jr (1988) Neonatal withdrawal symptoms after chronic maternal ingestion of caffeine. South Med J 81(9):1092–1094
Martin I, Lopez-Vilchez MA, Mur A, García-Algar O, Rossi S, Marchei E, Pichini S (2007) Neonatal withdrawal syndrome after chronic maternal drinking of mate. Ther Drug Monit 29(1):127–129
Pediatrics AAO (2001) Transfer of drugs and other chemicals into human milk. Pediatrics 108(3):776–789
Garcia-Algar O, Kulaga V, Gareri J, Koren G, Vall O, Zuccaro P, Pacifici R, Pichini S (2008) Alarming prevalence of fetal alcohol exposure in a Mediterranean city. Ther Drug Monit 30(2):249–254
da-Silva VA, Malheiros LR, Moraes-Santos AR, Barzano MA, McLean AE (1993) Ethanol pharmacokinetics in lactating women. Braz J Med Biol Res 26(10):1097–1103
Lawton ME (1985) Alcohol in breast milk. Aust NZ J Obstet Gynaecol 25(1):71–73
Ho E, Collantes A, Kapur BM, Moretti M, Koren G (2001) Alcohol and breast feeding: calculation of time to zero level in milk. Biol Neonate 80(3):219–222
Chien YC, Liu JF, Huang YJ, Hsu CS, Chao JC (2005) Alcohol levels in Chinese lactating mothers after consumption of alcoholic diet during postpartum "doing-the-month" ritual. Alcohol 37(3):143–150
Little RE, Anderson KW, Ervin CH, Worthington-Roberts B, Clarren SK (1989) Maternal alcohol use during breast-feeding and infant mental and motor development at one year. N Engl J Med 321(7):425–430
Mennella JA, Gerrish CJ (1998) Effects of exposure to alcohol in mother's milk on infant sleep. Pediatrics 101(5):E2
Mennella JA, Beauchamp GK (1991) The transfer of alcohol to human milk. Effects on flavor and the infant’s behavior. N Engl J Med 325(14):981–985
Lamminpaa A (1995) Alcohol intoxication in childhood and adolescence. Alcohol Alcohol 30(1):5–12
Bennett PN (1997) Drugs and human lactation. Elsevier, Amsterdam
Perez-Reyes M, Wall ME (1982) Presence of delta9-tetrahydrocannabinol in human milk. N Engl J Med 307(13):819–820
Liston J (1998) Breastfeeding and the use of recreational drugs—alcohol, caffeine, nicotine and marijuana. Breastfeed Rev 6(2):27–30
Astley SJ, Little RE (1990) Maternal marijuana use during lactation and infant development at one year. Neurotoxicol Teratol 12(2):161–168
Wiggins RC, Rolsten C, Ruiz B, Davis CM (1989) Pharmacokinetics of cocaine: basic studies of route, dosage, pregnancy and lactation. Neurotoxicology 10(3):367–381
Dickson PH, Lind A, Studts P, Nipper HC, Makoid M, Therkildsen D (1994) The routine analysis of breast milk for drugs of abuse in a clinical toxicology laboratory. J Forensic Sci 39(1):207–214
Winecker RE, Goldberger BA, Tebbett IR, Behnke M, Eyler FD, Karlix JL, Wobie K, Conlon M, Phillips D, Bertholf RL (2001) Detection of cocaine and its metabolites in breast milk. J Forensic Sci 46(5):1221–1223
Chasnoff IJ, Lewis DE, Squires L (1987) Cocaine intoxication in a breast-fed infant. Pediatrics 80(6):836–838
Lin LY, Di Stefano EW, Schmitz DA, Hsu L, Ellis SW, Lennard MS, Tucker GT, Cho AK (1997) Oxidation of methamphetamine and methylenedioxymethamphetamine by CYP2D6. Drug Metab Dispos 25(9):1059–1064
Steiner E, Villen T, Hallberg M, Rane A (1984) Amphetamine secretion in breast milk. Eur J Clin Pharmacol 27(1):123–124
Ilett KF, Hackett LP, Kristensen JH, Kohan R (2007) Transfer of dexamphetamine into breast milk during treatment for attention deficit hyperactivity disorder. Br J Clin Pharmacol 63(3):371–375
Bartu A, Dusci LJ, Ilett KF (2009) Transfer of methylamphetamine and amphetamine into breast milk following recreational use of methylamphetamine. Br J Clin Pharmacol 67(4):455–459
Ariagno R, Karch SB, Middleberg R, Stephens BG, Valdes-Dapena M (1995) Methamphetamine ingestion by a breast-feeding mother and her infant’s death: People v Henderson. JAMA 274(3):215
Wojnar-Horton RE, Kristensen JH, Yapp P, Ilett KF, Dusci LJ, Hackett LP (1997) Methadone distribution and excretion into breast milk of clients in a methadone maintenance programme. Br J Clin Pharmacol 44(6):543–547
Zuckschwerdt JB, Nixon CE, Ciner FL, Croley TR (2008) Liquid chromatography/quadrupole ion trap/time-of-flight determination of the efficacy of drug test kits for rapid screening of food. J Food Prot 71(5):1007–1014
Cobrinik RW, Hood RT Jr, Chusid E (1959) The effect of maternal narcotic addiction on the newborn infant; review of literature and report of 22 cases. Pediatrics 24(2):288–304
van de Velde S, Verloo P, Van Biervliet S, Robberecht E (2007) Heroin withdrawal leads to metabolic alkalosis in an infant with cystic fibrosis. Eur J Pediatr 166(1):75–76
Robinson AE, Williams FM (1971) The distribution of methadone in man. J Pharm Pharmacol 23(5):353–358
Totah RA, Sheffels P, Roberts T, Whittington D, Thummel K, Kharasch ED (2008) Role of CYP2B6 in stereoselective human methadone metabolism. Anesthesiology 108(3):363–374
Blinick G, Inturrisi CE, Jerez E, Wallach RC (1975) Methadone assays in pregnant women and progeny. Am J Obstet Gynecol 121(5):617–621
Kreek MJ (1979) Methadone disposition during the perinatal period in humans. Pharmacol Biochem Behav 11(Suppl):7–13
Geraghty B, Graham EA, Logan B, Weiss EL (1997) Methadone levels in breast milk. J Hum Lact 13(3):227–230
McCarthy JJ, Posey BL (2000) Methadone levels in human milk. J Hum Lact 16(2):115–120
Begg EJ, Malpas TJ, Hackett LP, Ilett KF (2001) Distribution of R- and S-methadone into human milk during multiple, medium to high oral dosing. Br J Clin Pharmacol 52(6):681–685
Choo RE, Jansson LM, Scheidweiler K, Huestis MA (2007) A validated liquid chromatography-atmospheric pressure chemical ionization–tandem mass spectrometric method for the quantification of methadone, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP), and 2-ethyl-5-methyl-3,3-diphenylpyroline (EMDP) in human breast milk. J Anal Toxicol 31(5):265–269
Jansson LM, Choo R, Velez ML, Lowe R, Huestis MA (2008) Methadone maintenance and long-term lactation. Breastfeed Med 3(1):34–37
Jansson LM, Choo R, Velez ML, Harrow C, Schroeder JR, Shakleya DM, Huestis MA (2008) Methadone maintenance and breastfeeding in the neonatal period. Pediatrics 121(1):106–114
Nikolaou PD, Papoutsis II, Maravelias CP, Spiliopoulou CA, Pistos CM, Calokerinos AC, Atta-Politou J (2008) Development and validation of an EI-GC-MS method for the determination of methadone and its major metabolites (EDDP and EMDP) in human breast milk. J Anal Toxicol 32(7):478–484
Abdel-Latif ME, Pinner J, Clews S, Cooke F, Lui K, Oei J (2006) Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers. Pediatrics 117(6):e1163–e1169
Malpas TJ, Darlow BA (1999) Neonatal abstinence syndrome following abrupt cessation of breastfeeding. NZ Med J 112(1080):12–13
Smialek JE, Monforte JR, Aronow R, Spitz WU (1977) Methadone deaths in children. A continuing problem. JAMA 238(23):2516–2517
Vert P, Hamon I, Hubert C, Legagneur M, Hascoet JM (2008) Infants of drug-addicted mothers: pitfalls of replacement therapy. Bull Acad Natl Med 192(5):961–969, discussion 9
Lindemalm S, Nydert P, Svensson JO, Stahle L, Sarman I (2009) Transfer of buprenorphine into breast milk and calculation of infant drug dose. J Hum Lact 25(2):199–205
Meny RG, Naumburg EG, Alger LS, Brill-Miller JL, Brown S (1993) Codeine and the breastfed neonate. J Hum Lact 9(4):237–240
Madadi P, Shirazi F, Walter FG, Koren G (2008) Establishing causality of CNS depression in breastfed infants following maternal codeine use. Paediatr Drugs 10(6):399–404
Madadi P, Koren G, Cairns J, Chitayat D, Gaedigk A,. Leeder JS, Teitelbaum R, Karaskov T, Aleksa K (2007) Safety of codeine during breastfeeding: fatal morphine poisoning in the breastfed neonate of a mother prescribed codeine. Can Fam Physician 53(1):33–35
Madadi P, Ross CJ, Hayden MR, Carleton BC, Gaedigk A, Leeder JS, Koren G (2009) Pharmacogenetics of neonatal opioid toxicity following maternal use of codeine during breastfeeding: a case-control study. Clin Pharmacol Ther 85(1):31–35
Ilett KF, Paech MJ, Page-Sharp M, Sy SK, Kristensen JH, Goy R, Chua S, Christmas T, Scott KL (2008) Use of a sparse sampling study design to assess transfer of tramadol and its O-desmethyl metabolite into transitional breast milk. Br J Clin Pharmacol 65(5):661–666
Baka NE, Bayoumeu F, Boutroy MJ, Laxenaire MC (2002) Colostrum morphine concentrations during postcesarean intravenous patient-controlled analgesia. Anesth Analg 94(1):184–187, table of contents
Oo CY, Kuhn RJ, Desai N, Wright CE, McNamara PJ (1995) Pharmacokinetics in lactating women: prediction of alprazolam transfer into milk. Br J Clin Pharmacol 40(3):231–236
Lebedevs TH, Wojnar-Horton RE, Yapp P, Roberts MJ, Dusci LJ, Hackett LP, Ilett KF (1992) Excretion of temazepam in breast milk. Br J Clin Pharmacol 33(2):204–206
Dusci LJ, Good SM, Hall RW, Ilett KF (1990) Excretion of diazepam and its metabolites in human milk during withdrawal from combination high dose diazepam and oxazepam. Br J Clin Pharmacol 29(1):123–126
Lemmer P, Schneider S, Muhe A, Wennig R (2007) Quantification of lorazepam and lormetazepam in human breast milk using GC-MS in the negative chemical ionization mode. J Anal Toxicol 31(4):224–226
Hagg S, Spigset O (2000) Anticonvulsant use during lactation. Drug Saf 22(6):425–440
Cole AP, Hailey DM (1975) Diazepam and active metabolite in breast milk and their transfer to the neonate. Arch Dis Child 50(9):741–742
Patrick MJ, Tilstone WJ, Reavey P (1972) Diazepam and breast-feeding. Lancet 1(7749):542–543
Wesson DR, Camber S, Harkey M, Smith DE (1985) Diazepam and desmethyldiazepam in breast milk. J Psychoact Drugs 17(1):55–56
Hale TW (2004) Medications and mother’s milk: a manual of lactational pharmacology, 11 edn. Pharmasoft, Amarillo
Iqbal MM, Sobhan T, Ryals T (2002) Effects of commonly used benzodiazepines on the fetus, the neonate, and the nursing infant. Psychiatr Serv 53(1):39–49
Iqbal MM, Sobhan T, Aftab SR, Mahmud SZ (2002) Diazepam use during pregnancy: a review of the literature. Del Med J 74(3):127–135
Epperson N, Czarkowski KA, Ward-O'Brien D, Weiss E, Gueorguieva R, Jatlow P, Anderson GM (2001) Maternal sertraline treatment and serotonin transport in breast-feeding mother-infant pairs. Am J Psychiatry 158(10):1631–1637
Burt VK, Suri R, Altshuler L, Stowe Z, Hendrick VC, Muntean E (2001) The use of psychotropic medications during breast-feeding. Am J Psychiatry 158(7):1001–1009
Yoshida K, Smith B, Craggs M, Kumar RC (1997) Investigation of pharmacokinetics and of possible adverse effects in infants exposed to tricyclic antidepressants in breast-milk. J Affect Disord 43(3):225–237
Taddio A, Ito S, Koren G (1996) Excretion of fluoxetine and its metabolite, norfluoxetine, in human breast milk. J Clin Pharmacol 36(1):42–47
Yoshida K, Smith B, Craggs M, Kumar RC (1998) Fluoxetine in breast-milk and developmental outcome of breast-fed infants. Br J Psychiatry 172:175–178
Lester BM, Cucca J, Andreozzi L, Flanagan P, Oh W (1993) Possible association between fluoxetine hydrochloride and colic in an infant. J Am Acad Child Adolesc Psych 32(6):1253–1255
Brent NB, Wisner KL (1998) Fluoxetine and carbamazepine concentrations in a nursing mother/infant pair. Clin Pediatr (Phila) 37(1):41–44
Chambers CD, Anderson PO, Thomas RG, Dick LM, Felix RJ, Johnson KA, Jones KL (1999) Weight gain in infants breastfed by mothers who take fluoxetine. Pediatrics 104(5):e61
Stowe ZN, Owens MJ, Landry JC, Kilts CD, Ely T, Llewellyn A, Nemeroff CB (1997) Sertraline and desmethylsertraline in human breast milk and nursing infants. Am J Psychiatry 154(9):1255–1260
Dodd S, Stocky A, Buist A, Burrows GD, Maguire K, Norman TR (2000) Sertraline in paired blood plasma and breast-milk samples from nursing mothers. Hum Psychopharmacol 15(4):161–264
Begg EJ, Duffull SB, Saunders DA, Buttimore RC, Ilett KF, Hackett LP, Yapp P, Wilson DA (1999) Paroxetine in human milk. Br J Clin Pharmacol 48(2):142–147
Stowe ZN, Cohen LS, Hostetter A, Ritchie JC, Owens MJ, Nemeroff CB (2000) Paroxetine in human breast milk and nursing infants. Am J Psychiatry 157(2):185–189
Misri S, Kim J, Riggs KW, Kostaras X (2000) Paroxetine levels in postpartum depressed women, breast milk, and infant serum. J Clin Psychiatry 61(11):828–832
Kemp J, Ilett KF, Booth J, Hackett LP (1985) Excretion of doxepin and N-desmethyldoxepin in human milk. Br J Clin Pharmacol 20(5):497–499
Matheson I, Pande H, Alertsen AR (1985) Respiratory depression caused by N-desmethyldoxepin in breast milk. Lancet 2(8464):1124
Frey OR, Scheidt P, von Brenndorff AI (1999) Adverse effects in a newborn infant breast-fed by a mother treated with doxepin. Ann Pharmacother 33(6):690–693
Wiles DH, Orr MW, Kolakowska T (1978) Chlorpromazine levels in plasma and milk of nursing mothers. Br J Clin Pharmacol 5(3):272–273
Whalley LJ, Blain PG, Prime JK (1981) Haloperidol secreted in breast milk. Br Med J (Clin Res Ed) 282(6278):1746–1747
Ohkubo T, Shimoyama R, Sugawara K (1992) Measurement of haloperidol in human breast milk by high-performance liquid chromatography. J Pharm Sci 81(9):947–949
Yoshida K, Smith B, Craggs M, Kumar R (1998) Neuroleptic drugs in breast-milk: a study of pharmacokinetics and of possible adverse effects in breast-fed infants. Psychol Med 28(1):81–91
Keltner NL, Coffeen H, Johnson JE (2000) Atypical antipsychotic drugs: Part 1. Perspect Psychiatr Care 36(3):101–104
Barnas C, Bergant A, Hummer M, Saria A, Fleischhacker WW (1994) Clozapine concentrations in maternal and fetal plasma, amniotic fluid, and breast milk. Am J Psychiatry 151(6):945
Trixler M, Tenyi T (1997) Antipsychotic use in pregnancy. What are the best treatment options? Drug Saf 16(6):403–410
Iqbal MM, Gundlapalli SP, Ryan WG, Ryals T, Passman TE (2001) Effects of antimanic mood-stabilizing drugs on fetuses, neonates, and nursing infants. South Med J 94(3):304–322
Kasper SC, Mattiuz EL, Swanson SP, Chiu JA, Johnson JT, Garner CO (1999) Determination of olanzapine in human breast milk by high-performance liquid chromatography with electrochemical detection. J Chromatogr B 726(1–2):203–209
Croke S, Buist A, Hackett LP, Ilett KF, Norman TR, Burrows GD (2002) Olanzapine excretion in human breast milk: estimation of infant exposure. Int J Neuropsychopharmacol 5(3):243–247
Gardiner SJ, Kristensen JH, Begg EJ, Hackett LP, Wilson DA, Ilett KF, Kohan R, Rampono J (2003) Transfer of olanzapine into breast milk, calculation of infant drug dose, and effect on breast-fed infants. Am J Psychiatry 160(8):1428–1431
Lutz UC, Wiatr G, Orlikowsky T, Gaertner HJ, Bartels M (2008) Olanzapine treatment during breast feeding: a case report. Ther Drug Monit 30(3):399–401
Friedman SH, Rosenthal MB (2003) Treatment of perinatal delusional disorder: a case report. Int J Psychiatry Med 33(4):391–394
Goldstein DJ, Corbin LA, Fung MC (2000) Olanzapine-exposed pregnancies and lactation: early experience. J Clin Psychopharmacol 20(4):399–403
Kirchheiner J, Berghofer A, Bolk-Weischedel D (2000) Healthy outcome under olanzapine treatment in a pregnant woman. Pharmacopsychiatry 33(2):78–80
Hill RC, McIvor RJ, Wojnar-Horton RE, Hackett LP, Ilett KF (2000) Risperidone distribution and excretion into human milk: case report and estimated infant exposure during breast-feeding. J Clin Psychopharmacol 20(2):285–286
Ilett KF, Hackett LP, Kristensen JH, Vaddadi KS, Gardiner SJ, Begg EJ (2004) Transfer of risperidone and 9-hydroxyrisperidone into human milk. Ann Pharmacother 38(2):273–276
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fríguls, B., Joya, X., García-Algar, O. et al. A comprehensive review of assay methods to determine drugs in breast milk and the safety of breastfeeding when taking drugs. Anal Bioanal Chem 397, 1157–1179 (2010). https://doi.org/10.1007/s00216-010-3681-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-010-3681-0